| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
|
FIGURE 1. (A) Kaplan–Meier survival curves of all 57 patients according to SUV of lung cancer. (B) Kaplan–Meier disease-free survival curves of all 57 patients according to SUV of lung cancer. (C and D) Kaplan–Meier disease-free survival curves of 46 patients with pathologic stage (pStage) I NSCLC (C) and 38 patients with pStage IA NSCLC (D) according to SUV of lung cancer. Curves reveal clear demarcation, with poor survival or disease-free survival of subjects in high-SUV group.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
